Abstract: The invention relates to novel conjugated polymers containing one or more [1,2,5]Thiadiazolo[3,4-e]isoindole-5,7-dione (TID) repeating units, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in, or for the preparation of, organic electronic (OE) devices, especially organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising, or being prepared from, these polymers, polymer blends, mixtures or formulations.
Type:
Application
Filed:
June 3, 2014
Publication date:
June 2, 2016
Applicant:
MERCK PATENT GMBH
Inventors:
Nicolas BLOUIN, Agnieszka PRON, Graham MORSE, Lana NANSON, Michal KROMPIEC, Stephane BERNY
Abstract: The present invention relates to compounds of the formula (1) which are suitable for use in electronic devices, in particular organic electroluminescent devices.
Type:
Grant
Filed:
August 7, 2014
Date of Patent:
May 31, 2016
Assignee:
Merck Patent GmbH
Inventors:
Amir Hossain Parham, Christof Pflumm, Teresa Mujica-Fernaud
Abstract: An organic electroluminescent device that includes at least two phosphorescent emitting layers, where phosphorescent emitter layer 1 comprises a hole-conducting matrix material and two different phosphorescent emitters, and phosphorescent emitter layer 2 comprises an electron-conducting matrix material and a phosphorescent emitter.
Abstract: The present invention relates to a method for producing solar cells with local back surface field (LBSF) using an alkaline etching paste which allows the back surface to be polished and the back surface edges to be insulated in a single process step.
Type:
Grant
Filed:
May 24, 2013
Date of Patent:
May 31, 2016
Assignee:
Merck Patent GmbH
Inventors:
Werner Stockum, Oliver Doll, Ingo Koehler, Christian Matuschek
Abstract: The present invention relates to microspheres, to a process for the production thereof, and to the use thereof, preferably as laser-absorbing additive.
Abstract: The present invention relates to compounds of the formula I and in particular medicaments comprising at least one compound of the formula I for use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
Abstract: The present invention relates to cell culture media comprising polymer embedded components. Some components show poor stability in dry powder cell culture media. Others are hygroscopic.
Type:
Application
Filed:
June 16, 2014
Publication date:
May 26, 2016
Applicant:
MERCK PATENT GMBH
Inventors:
Michael Howard RAYNER-BRANDES, Joerg VON HAGEN
Abstract: The invention pertains to an optical device comprising at least one glass or polymer area, whereby an active matrix is located in contact with the at least one glass or polymer area, the optical device comprises a power supply system located between a first auxiliary plane and a second auxiliary-plane parallel to a glass or polymer area, and a distance L from a third auxiliary-plane or a fourth auxiliary-plane approximately perpendicular to the glass or polymer area. The invention pertains also to a power supply system for such an optical device.
Abstract: The present invention relates to polymers which contain substituted indenofluorene derivatives as structural unit, to substituted indenofluorene derivatives, to a process for the preparation of the polymers according to the invention, to mixtures and solutions which comprise the polymers according to the invention, and to the use of the polymers according to the invention in electronic devices, in particular in organic electroluminescent devices, so-called OLEDs (OLED=organic light emitting diode).
Abstract: The invention relates to a method for producing tris(perfluoroalkyl)phosphine oxides and bis(perfluoroalkyl)phosphinic acids by reacting tris(perfluoroalkyl)difluorophosphorane or bis(perfluoroalkyl)trifluorophosphorane with non-metal oxides, metalloid oxides or organic compounds with basic oxygen residues.
Type:
Grant
Filed:
June 4, 2013
Date of Patent:
May 24, 2016
Assignee:
Merck Patent GmbH
Inventors:
Nikolai (Mykola) Ignatyev, Karsten Koppe, Walter Frank
Abstract: The present invention relates to polymerisable compounds, to processes and intermediates for the preparation thereof, to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays having a polymer-stabilised blue phase, and in LC media for LC displays of the PS or PSA (“polymer sustained” or “polymer sustained alignment”) type, and to LC media and LC displays comprising these compounds.
Type:
Grant
Filed:
August 26, 2014
Date of Patent:
May 24, 2016
Assignee:
Merck Patent GmbH
Inventors:
Axel Jansen, Andreas Taugerbeck, Helmut Haensel, Achim Goetz
Abstract: The present invention relates to compounds of the formula (I) and in particular medicaments comprising at least one compound of the formula (I) for use in the treatment and/or prophylaxis of physiological and/or pathophysiological states in the triggering of which cathepsin D is involved, in particular for use in the treatment and/or prophylaxis of arthrosis, traumatic cartilage injuries, arthritis, pain, allodynia or hyperalgesia.
Type:
Grant
Filed:
January 9, 2012
Date of Patent:
May 24, 2016
Assignee:
MERCK PATENT GMBH
Inventors:
Markus Klein, Christos Tsaklakidis, Hans Guehring, Brigitta Leuthner
Abstract: The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R1, R1*, L1, L2 and L3 have the meanings indicated in Claim 1, and to the use thereof for an active-matrix display, in particular based on the VA, PSA, PS-VA, PA-VA, PALC, FFS, PS-FFS, IPS or PS-IPS effect. The invention furthermore also relates to compounds of the formula I.
Type:
Grant
Filed:
February 27, 2012
Date of Patent:
May 24, 2016
Assignee:
Merck Patent GmbH
Inventors:
Melanie Klasen-Memmer, Matthias Bremer, Harald Lannert, Konstantin Schneider
Abstract: The present invention relates to transparent, optically variable, electrically semiconducting interference pigments, in particular flake-form interference pigments, which comprise an oxygen-deficient layer of Ti02-x, to a process for the preparation of such pigments, and to the use of the pigments prepared in this way.
Abstract: This invention relates to polymer particles, a process for their preparation, electrophoretic fluids comprising such particles, and electrophoretic display devices comprising such fluids.
Type:
Application
Filed:
May 20, 2014
Publication date:
May 19, 2016
Applicants:
MERCK PATENT GMBH, THE QUEEN'S UNIVERSITY OF BELFAST
Inventors:
Louise D. FARRAND, Nils GREINERT, Jonathan H. WILSON, Thomas BAUER, Claire TOPPING, Sarah NORMAN
Abstract: The present invention relates to transparent, electrically semiconducting interference pigments having high colour strength, and in particular to flake-form interference pigments which comprise an oxygen-deficient layer of TiO2-x, to a process for the preparation of such pigments, and to the use of the pigments prepared in this way.
Abstract: The present invention relates to a liquid crystal (LC) medium comprising a terphenyl compound and at least two polymerizable compounds, to a process for its preparation, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in an LC display of the polymer sustained alignment (PSA) type, and to an LC display, especially a PSA display, comprising it.
Abstract: The present invention relates to compounds having a spirobifluorene skeleton of the formula (I) for use as functional materials in electronic devices, in particular for use in the charge-transport layer and/or emission layer of organic electroluminescent devices. The invention furthermore relates to a process for the preparation of the compounds according to the invention and to mixtures comprising the compounds according to the invention. The invention furthermore relates to the use of the compounds of the formula (I) in electronic devices and to electronic devices comprising the compounds of the formula (I).
Type:
Grant
Filed:
February 28, 2011
Date of Patent:
May 17, 2016
Assignee:
Merck Patent GmbH
Inventors:
Heinrich Becker, Jochen Schwaiger, Hubert Spreitzer, Frank Voges, Holger Heil
Abstract: Compounds of the formula I in which U, V and W have the meanings indicated in Claim 1, are inhibitors of Tankyrase, and can be employed, inter alia, for the treatment of diseases such as cancer, cardiovascular diseases, central nervous system injury and different forms of inflammation.
Type:
Grant
Filed:
January 14, 2013
Date of Patent:
May 17, 2016
Assignee:
MERCK PATENT GMBH
Inventors:
Hans-Peter Buchstaller, Christina Esdar, Birgitta Leuthner
Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.